Managing Editor Randy Kubetin to moderate @IAmBiotech panel on June 6 at 4:15 p.m. on the legal & legislative issues surrounding Allergan's assignment of patents on its dry-eye drug Restasis to the St. Regis Mohawk Tribe. More info: http://on.bna.com/Raog30khi9l #Biotechpic.twitter.com/ExEgbWHyBY
12:43 PM - 31 May 2018
1 reply
3 retweets
2 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.
Follow our journalists: